HEADER GLYCOSIDASE 11-FEB-98 1A47 TITLE CGTASE FROM THERMOANAEROBACTERIUM THERMOSULFURIGENES EM1 IN COMPLEX TITLE 2 WITH A MALTOHEXAOSE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLODEXTRIN GLYCOSYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CGTASE; COMPND 5 EC: 2.4.1.19; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THERMOANAEROBACTERIUM THERMOSULFURIGENES; SOURCE 3 ORGANISM_TAXID: 33950; SOURCE 4 STRAIN: EM1; SOURCE 5 CELLULAR_LOCATION: EXTRACELLULAR; SOURCE 6 GENE: AMYA; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: PC1990; SOURCE 10 EXPRESSION_SYSTEM_CELLULAR_LOCATION: EXTRACELLULAR; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PCT2; SOURCE 12 EXPRESSION_SYSTEM_GENE: AMYA KEYWDS GLYCOSIDASE, THERMOSTABLE, FAMILY 13 GLYCOSYL HYDROLASE, LIGAND, KEYWDS 2 SUBSTRATE, ACARBOSE EXPDTA X-RAY DIFFRACTION AUTHOR J.C.M.UITDEHAAG,K.H.KALK,H.J.ROZEBOOM,B.W.DIJKSTRA REVDAT 7 22-MAY-24 1A47 1 REMARK REVDAT 6 02-AUG-23 1A47 1 HETSYN LINK REVDAT 5 29-JUL-20 1A47 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 20-NOV-19 1A47 1 LINK REVDAT 3 25-OCT-17 1A47 1 COMPND HET HETNAM HETSYN REVDAT 3 2 1 FORMUL LINK SITE ATOM REVDAT 2 24-FEB-09 1A47 1 VERSN REVDAT 1 17-JUN-98 1A47 0 JRNL AUTH R.D.WIND,J.C.UITDEHAAG,R.M.BUITELAAR,B.W.DIJKSTRA, JRNL AUTH 2 L.DIJKHUIZEN JRNL TITL ENGINEERING OF CYCLODEXTRIN PRODUCT SPECIFICITY AND PH JRNL TITL 2 OPTIMA OF THE THERMOSTABLE CYCLODEXTRIN GLYCOSYLTRANSFERASE JRNL TITL 3 FROM THERMOANAEROBACTERIUM THERMOSULFURIGENES EM1. JRNL REF J.BIOL.CHEM. V. 273 5771 1998 JRNL REFN ISSN 0021-9258 JRNL PMID 9488711 JRNL DOI 10.1074/JBC.273.10.5771 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.M.KNEGTEL,R.D.WIND,H.J.ROZEBOOM,K.H.KALK,R.M.BUITELAAR, REMARK 1 AUTH 2 L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL CRYSTAL STRUCTURE AT 2.3 A RESOLUTION AND REVISED NUCLEOTIDE REMARK 1 TITL 2 SEQUENCE OF THE THERMOSTABLE CYCLODEXTRIN REMARK 1 TITL 3 GLYCOSYLTRANSFERASE FROM THERMOANAEROBACTERIUM REMARK 1 TITL 4 THERMOSULFURIGENES EM1 REMARK 1 REF J.MOL.BIOL. V. 256 611 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.STROKOPYTOV,R.M.KNEGTEL,D.PENNINGA,H.J.ROZEBOOM,K.H.KALK, REMARK 1 AUTH 2 L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH REMARK 1 TITL 2 A MALTONONAOSE INHIBITOR AT 2.6 ANGSTROM RESOLUTION. REMARK 1 TITL 3 IMPLICATIONS FOR PRODUCT SPECIFICITY REMARK 1 REF BIOCHEMISTRY V. 35 4241 1996 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 2.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 5D REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.0 REMARK 3 NUMBER OF REFLECTIONS : 24483 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : R FREE THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : EVERY 14TH REFLECTION REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1956 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.1910 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1860 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 7.00 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1956 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 25423 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5333 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 102 REMARK 3 SOLVENT ATOMS : 185 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 17.900 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.003 ; 3.000 ; 5577 REMARK 3 BOND ANGLES (DEGREES) : 0.971 ; 8.000 ; 7601 REMARK 3 TORSION ANGLES (DEGREES) : 17.500; 0.000 ; 3141 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.007 ; 5.000 ; 143 REMARK 3 GENERAL PLANES (A) : 0.007 ; 30.000; 803 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 1.571 ; 5.000 ; 5575 REMARK 3 NON-BONDED CONTACTS (A) : 0.009 ; 40.000; 227 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : TNT PROTGEO REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : TNT BCORREL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL PARAMETERS FOR GLUCOSE FROM REMARK 3 TAKUSAGAWA & JACOBSON (1978), ACTA CRYST. B34:213-218, FOR REMARK 3 ACARBOSE FROM STROKOPYTOV ET AL. (1995) BIOCHEMISTRY 34:2234-2240 REMARK 4 REMARK 4 1A47 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170371. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-96 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 7.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ELLIOTT GX-21 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAC SCIENCE DIP-2020 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : BIOMOL (KBAPLY) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25423 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.560 REMARK 200 RESOLUTION RANGE LOW (A) : 45.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.06820 REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.21550 REMARK 200 R SYM FOR SHELL (I) : 0.22000 REMARK 200 FOR SHELL : 4.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BIOMOL REMARK 200 STARTING MODEL: PDB ENTRY 1CIU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21% SATURATED AMMONIUM SULFATE, 100 MM REMARK 280 TRIS, PH 7.7 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.99800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.13150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.89450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.13150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.99800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.89450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ELECTRON DENSITY IN THE ACTIVE SITE, BETWEEN SUBSITES -1 REMARK 400 AND +1 (THE SCISSILE BOND), IS NOT COMPATIBLE WITH EITHER REMARK 400 A CONTINUOUS MALTOHEXAOSE INHIBITOR, A COVALENT REMARK 400 INTERMEDIATE + ACCEPTOR, OR TWO SEPARATE TRIOSES. PROBABLY REMARK 400 AN AVERAGE IS OBSERVED, BUT THE LOW RESOLUTION DOESN'T REMARK 400 ALLOW THIS TO BE MODELLED. TO ENSURE A REASONABLE FIT TO REMARK 400 THE ELECTRON DENSITY, REFINEMENT RESTRAINTS ON THE REMARK 400 SCISSILE BOND WERE LOOSENED, RESULTING IN A LONGER REMARK 400 SCISSILE BOND (2.3 A, NORMAL: 1.47 A). REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 15 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 27 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 37 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 53 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 63 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 89 CB - CG - OD1 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP A 105 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 149 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 ASP A 171 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 189 CB - CG - OD1 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 197 CB - CG - OD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 ASP A 225 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 283 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 296 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 305 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 314 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 ASP A 329 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 331 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 371 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP A 417 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP A 417 CB - CG - OD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ASP A 458 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 ASP A 474 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 22 -57.25 -18.54 REMARK 500 PHE A 25 -78.00 -97.01 REMARK 500 HIS A 43 30.79 75.52 REMARK 500 TRP A 102 76.61 -104.11 REMARK 500 ARG A 104 -33.28 -132.04 REMARK 500 ASN A 130 30.39 73.75 REMARK 500 THR A 142 -89.31 -109.85 REMARK 500 PRO A 150 0.60 -67.80 REMARK 500 ALA A 153 -132.99 53.08 REMARK 500 HIS A 178 57.42 -102.70 REMARK 500 PHE A 196 -122.29 77.01 REMARK 500 ALA A 231 47.82 39.14 REMARK 500 ARG A 251 100.77 -168.70 REMARK 500 ARG A 295 -68.70 -104.61 REMARK 500 PHE A 324 154.08 177.68 REMARK 500 THR A 379 -78.17 -57.73 REMARK 500 ASN A 415 -155.59 -135.46 REMARK 500 SER A 439 -0.18 -149.68 REMARK 500 ASN A 575 45.52 71.91 REMARK 500 ALA A 593 65.85 -100.29 REMARK 500 ASN A 624 41.43 -159.08 REMARK 500 GLN A 625 -69.99 -137.57 REMARK 500 VAL A 626 -82.69 -55.50 REMARK 500 TYR A 635 143.22 -173.77 REMARK 500 THR A 656 140.27 175.70 REMARK 500 SER A 672 -85.80 -116.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 686 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 27 OD1 REMARK 620 2 ASN A 29 O 70.8 REMARK 620 3 ASN A 32 OD1 140.8 70.5 REMARK 620 4 ASN A 33 OD1 90.4 98.7 101.0 REMARK 620 5 GLY A 51 O 76.3 142.2 136.5 99.5 REMARK 620 6 ASP A 53 OD2 86.3 79.3 81.0 176.6 80.6 REMARK 620 7 HOH A 840 O 147.2 141.5 71.9 80.3 74.4 103.0 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 685 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 140 OD1 REMARK 620 2 ILE A 191 O 151.7 REMARK 620 3 ASP A 200 OD1 84.4 121.6 REMARK 620 4 ASP A 200 OD2 126.8 81.2 51.3 REMARK 620 5 HIS A 234 O 72.6 79.3 144.4 160.4 REMARK 620 6 HOH A 838 O 94.0 83.1 75.9 100.4 79.0 REMARK 620 7 HOH A 839 O 107.7 66.7 128.0 85.1 85.6 148.2 REMARK 620 8 HOH A 882 O 70.8 125.0 71.6 68.4 122.6 145.1 66.0 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CA1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CALCIUM BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: CA2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CALCIUM BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: BS3 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: SUGAR BINDING SITE 3 (HOMOLOGOUS TO MBS3 IN PDB REMARK 800 ENTRY 1CDG). REMARK 800 REMARK 800 SITE_IDENTIFIER: AM3 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: SUGAR BINDING SUBSITE -3 IN THE ACTIVE SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AM2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: SUGAR BINDING SUBSITE -2 IN THE ACTIVE SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AM1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: SUGAR BINDING SUBSITE -1 IN THE ACTIVE SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AP1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: SUGAR BINDING SUBSITE +1 IN THE ACTIVE SITE REMARK 800 (CATALYTIC SITE). REMARK 800 REMARK 800 SITE_IDENTIFIER: AP2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: SUGAR BINDING SUBSITE +2 IN THE ACTIVE SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AP3 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: SUGAR BINDING SUBSITE +3 IN THE ACTIVE SITE. DBREF 1A47 A 1 683 UNP P26827 CDGT_THETU 28 710 SEQRES 1 A 683 ALA SER ASP THR ALA VAL SER ASN VAL VAL ASN TYR SER SEQRES 2 A 683 THR ASP VAL ILE TYR GLN ILE VAL THR ASP ARG PHE VAL SEQRES 3 A 683 ASP GLY ASN THR SER ASN ASN PRO THR GLY ASP LEU TYR SEQRES 4 A 683 ASP PRO THR HIS THR SER LEU LYS LYS TYR PHE GLY GLY SEQRES 5 A 683 ASP TRP GLN GLY ILE ILE ASN LYS ILE ASN ASP GLY TYR SEQRES 6 A 683 LEU THR GLY MET GLY VAL THR ALA ILE TRP ILE SER GLN SEQRES 7 A 683 PRO VAL GLU ASN ILE TYR ALA VAL LEU PRO ASP SER THR SEQRES 8 A 683 PHE GLY GLY SER THR SER TYR HIS GLY TYR TRP ALA ARG SEQRES 9 A 683 ASP PHE LYS ARG THR ASN PRO TYR PHE GLY SER PHE THR SEQRES 10 A 683 ASP PHE GLN ASN LEU ILE ASN THR ALA HIS ALA HIS ASN SEQRES 11 A 683 ILE LYS VAL ILE ILE ASP PHE ALA PRO ASN HIS THR SER SEQRES 12 A 683 PRO ALA SER GLU THR ASP PRO THR TYR ALA GLU ASN GLY SEQRES 13 A 683 ARG LEU TYR ASP ASN GLY THR LEU LEU GLY GLY TYR THR SEQRES 14 A 683 ASN ASP THR ASN GLY TYR PHE HIS HIS TYR GLY GLY THR SEQRES 15 A 683 ASP PHE SER SER TYR GLU ASP GLY ILE TYR ARG ASN LEU SEQRES 16 A 683 PHE ASP LEU ALA ASP LEU ASN GLN GLN ASN SER THR ILE SEQRES 17 A 683 ASP SER TYR LEU LYS SER ALA ILE LYS VAL TRP LEU ASP SEQRES 18 A 683 MET GLY ILE ASP GLY ILE ARG LEU ASP ALA VAL LYS HIS SEQRES 19 A 683 MET PRO PHE GLY TRP GLN LYS ASN PHE MET ASP SER ILE SEQRES 20 A 683 LEU SER TYR ARG PRO VAL PHE THR PHE GLY GLU TRP PHE SEQRES 21 A 683 LEU GLY THR ASN GLU ILE ASP VAL ASN ASN THR TYR PHE SEQRES 22 A 683 ALA ASN GLU SER GLY MET SER LEU LEU ASP PHE ARG PHE SEQRES 23 A 683 SER GLN LYS VAL ARG GLN VAL PHE ARG ASP ASN THR ASP SEQRES 24 A 683 THR MET TYR GLY LEU ASP SER MET ILE GLN SER THR ALA SEQRES 25 A 683 SER ASP TYR ASN PHE ILE ASN ASP MET VAL THR PHE ILE SEQRES 26 A 683 ASP ASN HIS ASP MET ASP ARG PHE TYR ASN GLY GLY SER SEQRES 27 A 683 THR ARG PRO VAL GLU GLN ALA LEU ALA PHE THR LEU THR SEQRES 28 A 683 SER ARG GLY VAL PRO ALA ILE TYR TYR GLY THR GLU GLN SEQRES 29 A 683 TYR MET THR GLY ASN GLY ASP PRO TYR ASN ARG ALA MET SEQRES 30 A 683 MET THR SER PHE ASN THR SER THR THR ALA TYR ASN VAL SEQRES 31 A 683 ILE LYS LYS LEU ALA PRO LEU ARG LYS SER ASN PRO ALA SEQRES 32 A 683 ILE ALA TYR GLY THR THR GLN GLN ARG TRP ILE ASN ASN SEQRES 33 A 683 ASP VAL TYR ILE TYR GLU ARG LYS PHE GLY ASN ASN VAL SEQRES 34 A 683 ALA LEU VAL ALA ILE ASN ARG ASN LEU SER THR SER TYR SEQRES 35 A 683 ASN ILE THR GLY LEU TYR THR ALA LEU PRO ALA GLY THR SEQRES 36 A 683 TYR THR ASP VAL LEU GLY GLY LEU LEU ASN GLY ASN SER SEQRES 37 A 683 ILE SER VAL ALA SER ASP GLY SER VAL THR PRO PHE THR SEQRES 38 A 683 LEU SER ALA GLY GLU VAL ALA VAL TRP GLN TYR VAL SER SEQRES 39 A 683 SER SER ASN SER PRO LEU ILE GLY HIS VAL GLY PRO THR SEQRES 40 A 683 MET THR LYS ALA GLY GLN THR ILE THR ILE ASP GLY ARG SEQRES 41 A 683 GLY PHE GLY THR THR SER GLY GLN VAL LEU PHE GLY SER SEQRES 42 A 683 THR ALA GLY THR ILE VAL SER TRP ASP ASP THR GLU VAL SEQRES 43 A 683 LYS VAL LYS VAL PRO SER VAL THR PRO GLY LYS TYR ASN SEQRES 44 A 683 ILE SER LEU LYS THR SER SER GLY ALA THR SER ASN THR SEQRES 45 A 683 TYR ASN ASN ILE ASN ILE LEU THR GLY ASN GLN ILE CYS SEQRES 46 A 683 VAL ARG PHE VAL VAL ASN ASN ALA SER THR VAL TYR GLY SEQRES 47 A 683 GLU ASN VAL TYR LEU THR GLY ASN VAL ALA GLU LEU GLY SEQRES 48 A 683 ASN TRP ASP THR SER LYS ALA ILE GLY PRO MET PHE ASN SEQRES 49 A 683 GLN VAL VAL TYR GLN TYR PRO THR TRP TYR TYR ASP VAL SEQRES 50 A 683 SER VAL PRO ALA GLY THR THR ILE GLN PHE LYS PHE ILE SEQRES 51 A 683 LYS LYS ASN GLY ASN THR ILE THR TRP GLU GLY GLY SER SEQRES 52 A 683 ASN HIS THR TYR THR VAL PRO SER SER SER THR GLY THR SEQRES 53 A 683 VAL ILE VAL ASN TRP GLN GLN HET GLC B 1 12 HET GLC B 2 11 HET GLC B 3 11 HET GLC C 1 12 HET GLC C 2 11 HET G6D C 3 9 HET GLC D 1 12 HET GLC D 2 11 HET ADH A 694 11 HET CA A 685 1 HET CA A 686 1 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM G6D ALPHA-D-QUINOVOPYRANOSE HETNAM ADH 1-AMINO-2,3-DIHYDROXY-5-HYDROXYMETHYL CYCLOHEX-5-ENE HETNAM CA CALCIUM ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN G6D ALPHA-D-QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOPYRANOSE; D- HETSYN 2 G6D QUINOVOSE; QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOSE FORMUL 2 GLC 7(C6 H12 O6) FORMUL 3 G6D C6 H12 O5 FORMUL 5 ADH C7 H13 N O3 FORMUL 6 CA 2(CA 2+) FORMUL 8 HOH *185(H2 O) HELIX 1 1 THR A 22 ARG A 24 5 3 HELIX 2 2 GLY A 36 LEU A 38 5 3 HELIX 3 3 TRP A 54 ASN A 62 1 9 HELIX 4 4 TYR A 65 MET A 69 1 5 HELIX 5 5 PHE A 116 HIS A 129 1 14 HELIX 6 6 ASP A 189 TYR A 192 1 4 HELIX 7 7 SER A 206 MET A 222 1 17 HELIX 8 8 PHE A 237 ARG A 251 1 15 HELIX 9 9 VAL A 268 GLU A 276 1 9 HELIX 10 10 PHE A 284 PHE A 294 1 11 HELIX 11 11 MET A 301 ASP A 314 1 14 HELIX 12 12 ILE A 318 ASP A 320 5 3 HELIX 13 13 ARG A 340 THR A 351 1 12 HELIX 14 14 TYR A 373 ARG A 375 5 3 HELIX 15 15 THR A 386 SER A 400 1 15 HELIX 16 16 PRO A 402 TYR A 406 1 5 HELIX 17 17 ALA A 608 LEU A 610 5 3 HELIX 18 18 THR A 615 LYS A 617 5 3 SHEET 1 A 6 PRO A 356 TYR A 359 0 SHEET 2 A 6 VAL A 16 ILE A 20 1 N ILE A 17 O PRO A 356 SHEET 3 A 6 ALA A 73 ILE A 76 1 N ALA A 73 O TYR A 18 SHEET 4 A 6 LYS A 132 PHE A 137 1 N LYS A 132 O ILE A 74 SHEET 5 A 6 GLY A 226 LEU A 229 1 N GLY A 226 O ILE A 135 SHEET 6 A 6 PHE A 254 GLY A 257 1 N PHE A 254 O ILE A 227 SHEET 1 B 4 VAL A 487 TYR A 492 0 SHEET 2 B 4 ASN A 428 ASN A 435 -1 N ALA A 433 O ALA A 488 SHEET 3 B 4 VAL A 418 PHE A 425 -1 N PHE A 425 O ASN A 428 SHEET 4 B 4 THR A 408 ILE A 414 -1 N TRP A 413 O ILE A 420 SHEET 1 C 2 TYR A 442 ILE A 444 0 SHEET 2 C 2 PHE A 480 LEU A 482 -1 N LEU A 482 O TYR A 442 SHEET 1 D 2 GLY A 454 TYR A 456 0 SHEET 2 D 2 ILE A 469 VAL A 471 -1 N VAL A 471 O GLY A 454 SHEET 1 E 3 MET A 508 LYS A 510 0 SHEET 2 E 3 ILE A 576 LEU A 579 1 N ASN A 577 O THR A 509 SHEET 3 E 3 GLY A 556 TYR A 558 -1 N TYR A 558 O ILE A 576 SHEET 1 F 4 LEU A 500 GLY A 505 0 SHEET 2 F 4 THR A 514 ARG A 520 -1 N ARG A 520 O LEU A 500 SHEET 3 F 4 GLU A 545 LYS A 549 -1 N VAL A 548 O ILE A 515 SHEET 4 F 4 THR A 537 TRP A 541 -1 N SER A 540 O LYS A 547 SHEET 1 G 2 GLN A 528 PHE A 531 0 SHEET 2 G 2 ILE A 560 LYS A 563 -1 N LYS A 563 O GLN A 528 SHEET 1 H 3 TRP A 633 PRO A 640 0 SHEET 2 H 3 GLN A 583 ASN A 591 -1 N VAL A 590 O TRP A 633 SHEET 3 H 3 GLY A 675 ASN A 680 1 N GLY A 675 O ARG A 587 SHEET 1 I 3 ASN A 600 GLY A 605 0 SHEET 2 I 3 THR A 644 LYS A 652 -1 N LYS A 652 O ASN A 600 SHEET 3 I 3 HIS A 665 THR A 668 -1 N TYR A 667 O ILE A 645 SHEET 1 J 2 ILE A 650 LYS A 652 0 SHEET 2 J 2 ILE A 657 TRP A 659 -1 N THR A 658 O LYS A 651 SHEET 1 K 2 LEU A 158 ASP A 160 0 SHEET 2 K 2 THR A 163 GLY A 166 -1 N GLY A 166 O LEU A 158 LINK N1 ADH A 694 C4 G6D C 3 1555 1555 1.47 LINK C4 ADH A 694 O1 GLC D 1 1555 1555 1.45 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.41 LINK O4 GLC B 2 C1 GLC B 3 1555 1555 1.41 LINK O4 GLC C 1 C1 GLC C 2 1555 1555 1.41 LINK O4 GLC C 2 C1 G6D C 3 1555 1555 1.41 LINK O4 GLC D 1 C1 GLC D 2 1555 1555 1.41 LINK OD1 ASP A 27 CA CA A 686 1555 1555 2.47 LINK O ASN A 29 CA CA A 686 1555 1555 2.32 LINK OD1 ASN A 32 CA CA A 686 1555 1555 2.44 LINK OD1 ASN A 33 CA CA A 686 1555 1555 2.06 LINK O GLY A 51 CA CA A 686 1555 1555 2.50 LINK OD2 ASP A 53 CA CA A 686 1555 1555 2.15 LINK OD1 ASN A 140 CA CA A 685 1555 1555 2.34 LINK O ILE A 191 CA CA A 685 1555 1555 2.52 LINK OD1 ASP A 200 CA CA A 685 1555 1555 2.54 LINK OD2 ASP A 200 CA CA A 685 1555 1555 2.62 LINK O HIS A 234 CA CA A 685 1555 1555 2.44 LINK CA CA A 685 O HOH A 838 1555 1555 2.75 LINK CA CA A 685 O HOH A 839 1555 1555 2.60 LINK CA CA A 685 O HOH A 882 1555 1555 2.37 LINK CA CA A 686 O HOH A 840 1555 1555 2.46 CISPEP 1 ASP A 371 PRO A 372 0 2.26 CISPEP 2 GLY A 505 PRO A 506 0 -1.07 CISPEP 3 GLY A 620 PRO A 621 0 0.39 CISPEP 4 TYR A 630 PRO A 631 0 4.29 SITE 1 CA1 6 ASP A 27 ASN A 29 ASN A 32 ASN A 33 SITE 2 CA1 6 GLY A 51 ASP A 53 SITE 1 CA2 4 ASN A 140 ILE A 191 ASP A 200 HIS A 234 SITE 1 BS3 7 GLC B 1 GLC B 2 GLC B 3 TRP A 413 SITE 2 BS3 7 GLN A 411 ILE A 414 GLY A 446 SITE 1 AM3 4 GLC C 1 GLU A 265 THR A 263 ASN A 591 SITE 1 AM2 4 GLC C 2 LYS A 233 PHE A 184 PHE A 260 SITE 1 AM1 3 G6D C 3 HIS A 234 GLU A 258 SITE 1 AP1 8 ADH A 694 TYR A 101 HIS A 141 ARG A 228 SITE 2 AP1 8 ASP A 230 GLU A 258 HIS A 328 ASP A 329 SITE 1 AP2 4 GLC D 1 TRP A 102 ASP A 371 ARG A 375 SITE 1 AP3 2 GLC D 2 LYS A 47 CRYST1 73.996 97.789 116.263 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013514 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010226 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008601 0.00000